Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026)
Cytosorbents' (CTSO) quarterly Amortizatization of Intangibles came in at $291000.0 in Q1 2026, up 53.16% YoY from $190000.0 in Q1 2025, and up 166.74% on a QoQ basis from -$436000.0 in Q4 2025.
Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Amortizatization of Intangibles data on file, last reported at $291000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 53.16% year-over-year to $291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $236000.0 (down 25.8% YoY) and the FY2025 annual result came in at $135000.0, down 22.41% from the prior year.
- Amortizatization of Intangibles grew to $291000.0 in Q1 2026, from -$436000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $499000.0 in Q3 2025 to a low of -$436000.0 in Q4 2025.
- A 5-year average of $83139.1 and a median of $55441.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 984.78% in 2025, down 1311.11% in 2025.
- Tracing CTSO's Amortizatization of Intangibles over 5 years: stood at $55441.0 in 2022, then jumped by 617.94% to $398035.0 in 2023, then slumped by 90.96% to $36000.0 in 2024, then sank by 1311.11% to -$436000.0 in 2025, then soared by 166.74% to $291000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $291000.0 (Q1 2026), -$436000.0 (Q4 2025), and $499000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | Cytosorbents | 21.57 Mn | 17.16 Mn | 7.05 Mn | 282,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 282,000.00 |
| Jun 30, 2026 | 282,000.00 |
| Mar 31, 2026 | 291,000.00 |
| Mar 31, 2026 | 291,000.00 |
| Dec 31, 2025 | -436,000.00 |
| Dec 31, 2025 | -436,000.00 |
| Sep 30, 2025 | 499,000.00 |
| Sep 30, 2025 | 499,000.00 |
| Jun 30, 2025 | -118,000.00 |
| Jun 30, 2025 | -118,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,073.00 |
| Jun 30, 2024 | 46,073.00 |
| Mar 31, 2024 | 45,927.00 |
| Mar 31, 2024 | 45,927.00 |